ICH: Revised ICH Q1 Draft for Consultation
ICH Q1 is a consolidated revision that supersedes ICH Q1A-F and Q5C (quality of biotechological products) guidelines and provides additional guidance on principles relating to stability. It also introduces new topics, including advanced therapies, bracketing and matrixing, stability modeling, and guidance on reference standards and novel excipients.
The document has reached Step 2 of the ICH process and is now open for public consultation.
Sources:
ICH: ICH: Draft Q1Guideline Step 2
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be Interested in the Following Articles:
